Antibe Therapeutics Inc(Pre-Merger) ATBPF

Need for Additional Financing

[Hideaway]

Can someone comment on the possibility over the next six months as to the likelihood of further dilution due the need for additional funding.
Yesterday's 27% drop in Shareprice was much more than I expected but new financing would certainly not help restore any stability.

[InTheKnight]

This is only my opinion based on my own analysis and what I would do if I were in their shoes.  They have plenty of cash on hand to fund the full phase II trial and beyond. Once completed this would give them a privileged position to sign exclusivity deals with big pharma that will bring in some revenue while they prepare for next stages. Directors don't want more diluted stock as they

[Harper75]

I agree with InTheKnight's opinion.  Also, by my calculation, we experienced a 177.5% price increase since Oct 17th lows without much of a pullback.  Larger than I wanted as well but we also have had many months in the 40's/50's - doubling up is a tempting profilt to take.

[MrMugsy]

Even though the volume looks healthier now - it isn't. It was never healthy in P1 or P2 during chronic either because of the make-up of characters. We have too many flippers - that's what causes this movement. Therefore - I don't care about price right now. Dilution?  Sure.  But not yet. Company is going to focus on P2 and during that time, you won't see any dilution